These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21957668)

  • 1. Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naïve persons visiting a voluntary testing and counselling centre in northeastern South Africa.
    Nwobegahay JM; Bessong PO; Masebe TM; Mavhandu LG; Iweriebor BC; Selabe G
    J Health Popul Nutr; 2011 Aug; 29(4):303-9. PubMed ID: 21957668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of drug-resistant mutations in newly diagnosed drug-naïve HIV-1-infected individuals in a treatment site in the waterberg district, limpopo province.
    Nwobegahay J; Bessong P; Masebe T; Mavhandu L; Manhaeve C; Ndjeka N; Selabe G
    S Afr Med J; 2011 May; 101(5):335-7. PubMed ID: 21837878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil.
    Carvalho BC; Cardoso LP; Damasceno S; Stefani MM
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1081-7. PubMed ID: 21417758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Resistance Mutations in a Population Before Antiretroviral Therapy Initiation in Northern South Africa.
    Ogola B; Matume ND; Mavhandu-Ramarumo LG; Tebit DM; Bessong PO
    AIDS Res Hum Retroviruses; 2022 Mar; 38(3):248-256. PubMed ID: 34107774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 diversity in an antiretroviral treatment naïve cohort from Bushbuckridge, Mpumalanga Province, South Africa.
    Msimanga PW; Vardas E; Engelbrecht S
    Virol J; 2015 Feb; 12():24. PubMed ID: 25889106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naïve patients entering antiretroviral treatment programs at two sites in northern South Africa.
    Nwobegahay J; Selabe G; Ndjeka NO; Manhaeve C; Bessong PO
    J Med Virol; 2012 Dec; 84(12):1839-43. PubMed ID: 23080485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral drug resistance and HIV-1 subtypes among treatment-naive prisoners in Kelantan, Malaysia.
    Ariffin TA; Mohamad S; Yusuf WN; Shueb RH
    J Infect Dev Ctries; 2014 Aug; 8(8):1063-7. PubMed ID: 25116676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].
    Yalçınkaya T; Köse S
    Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Genetics and the Incidence of Transmitted Drug Resistance Among Pre-Treatment HIV-1 Infected Patients in the Eastern Cape, South Africa.
    Digban TO; Iweriebor BC; Obi LC; Nwodo U; Okoh AI
    Curr HIV Res; 2019; 17(5):335-342. PubMed ID: 31584370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.
    Pérez-Alvarez L; Carmona R; Muñoz M; Delgado E; Thomson MM; Contreras G; Pedreira JD; Rodríguez Real R; Vázquez de Parga E; Medrano L; Taboada JA; Nájera R;
    Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.
    Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM
    AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.
    Steegen K; Carmona S; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; MacLeod W; Sanne I; Stevens WS
    PLoS One; 2016; 11(12):e0166305. PubMed ID: 27907009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.
    Cardoso LP; Pereira GA; Viegas AA; Schmaltz LE; Stefani MM
    J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors.
    Sá-Ferreira JA; Brindeiro PA; Chequer-Fernandez S; Tanuri A; Morgado MG
    Transfusion; 2007 Jan; 47(1):97-102. PubMed ID: 17207236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
    Ferreira AS; Cardoso LP; Stefani MM
    J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of HIV-1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia.
    Dvali N; Parker MM; Chkhartishvili N; Sharvadze L; Gochitashvili N; Abutidze A; Karchava M; DeHovitz JA; Tsertsvadze T
    J Med Virol; 2012 Jul; 84(7):1002-8. PubMed ID: 22585715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
    Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
    Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010.
    de Felipe B; Pérez-Romero P; Abad-Fernández M; Fernandez-Cuenca F; Martinez-Fernandez FJ; Trastoy M; Mata Rdel C; López-Cortés LF; Leal M; Viciana P; Vallejo A
    Virol J; 2011 Aug; 8():416. PubMed ID: 21871090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.